Hamps Bio Ltd — Others, 04-08-2025: AGM/EGM

Hamps Bio Ltd. will convene its 18th Annual General Meeting to adopt the financial results for the half-year and year ended March 31, 2025. A key proposal involves increasing the authorized share capital from Rs. 5 Cr to Rs. 10 Cr. This expansion is crucial to facilitate a planned 1:1 bonus share issuance, which will capitalize Rs. 4.356 Cr from company reserves. This strategic move aims to enhance liquidity and encourage broader retail investor engagement. Shareholders will also consider the re-appointment of a director and the appointment of new secretarial auditors.